{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:46:48Z","timestamp":1793778408990,"version":"4.6.1"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Maternal symptoms of preeclampsia (PE) are primarily driven by excess anti-angiogenic factors originating from the placenta. Chief among these are soluble Flt1 proteins (sFlt1s) produced from alternatively polyadenylated mRNA isoforms. Here we used polyadenylation site sequencing (PAS-Seq) of RNA from normal and PE human placentae to interrogate transcriptome-wide gene expression and alternative polyadenylation signatures associated with early-onset PE (EO-PE; symptom onset &lt;\u200934 weeks) and late-onset PE (LO-PE; symptom onset &gt;\u200934 weeks) cohorts. While we observed no general shift in alternative polyadenylation associated with PE, the EO-PE and LO-PE cohorts do exhibit gene expression profiles distinct from both each other and from normal placentae. The only two genes upregulated across all transcriptome-wide PE analyses to date (microarray, RNA-Seq and PAS-Seq) are NRIP1 (RIP140), a transcriptional co-regulator linked to metabolic syndromes associated with obesity, and Flt1. Consistent with sFlt1 overproduction being a significant driver of clinical symptoms, placental Flt1 mRNA levels strongly correlate with maternal blood pressure. For Flt1, just three mRNA isoforms account for &gt;\u200994% of all transcripts, with increased transcription of the entire locus driving Flt1 upregulation in both EO-PE and LO-PE. These three isoforms thus represent potential targets for therapeutic RNA interference (RNAi) in both early and late presentations.<\/jats:p>","DOI":"10.1038\/s41598-017-11639-6","type":"journal-article","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T08:11:01Z","timestamp":1505722261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia"],"prefix":"10.1038","volume":"7","author":[{"given":"Ami","family":"Ashar-Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9725-7536","authenticated-orcid":false,"given":"Yasin","family":"Kaymaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4975-6082","authenticated-orcid":false,"given":"Augustine","family":"Rajakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Ananth","family":"Karumanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,22]]},"reference":[{"key":"11639_CR1","doi-asserted-by":"publisher","first-page":"f6564","DOI":"10.1136\/bmj.f6564","volume":"347","author":"CV Ananth","year":"2013","unstructured":"Ananth, C. V., Keyes, K. M. & Wapner, R. J. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ \n                           347, f6564\u2013f6564 (2013).","journal-title":"BMJ"},{"key":"11639_CR2","first-page":"329","volume":"33","author":"T Shih","year":"2016","unstructured":"Shih, T. et al. The Rising Burden of Preeclampsia in the United States Impacts Both Maternal and Child Health. Amer J Perinatol \n                           33, 329\u2013338 (2016).","journal-title":"Amer J Perinatol"},{"key":"11639_CR3","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1097\/HJH.0b013e328344a82c","volume":"29","author":"JH Kang","year":"2011","unstructured":"Kang, J. H. et al. Preeclampsia leads to dysregulation of various signaling pathways in placenta. Journal of Hypertension \n                           29, 928\u2013936 (2011).","journal-title":"Journal of Hypertension"},{"key":"11639_CR4","doi-asserted-by":"crossref","unstructured":"Chaiworapongsa, T. et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. YMOB \n                           190, 1541\u20137\u2013 discussion 1547\u201350 (2004).","DOI":"10.1016\/j.ajog.2004.03.043"},{"key":"11639_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1081\/PRG-120021060","volume":"22","author":"P Dadelszen von","year":"2003","unstructured":"Dadelszen von, P., Magee, L. A. & Roberts, J. M. Subclassification of preeclampsia. Hypertens Pregnancy \n                           22, 143\u2013148 (2003).","journal-title":"Hypertens Pregnancy"},{"key":"11639_CR6","doi-asserted-by":"crossref","unstructured":"Romero, R. et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal & Neonatal Med \n                           21, 9\u201323 (2009).","DOI":"10.1080\/14767050701830480"},{"key":"11639_CR7","doi-asserted-by":"crossref","unstructured":"Kusanovic, J. P. et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine, 22(11), 1021\u20131038 (2009).\u00a0","DOI":"10.3109\/14767050902994754"},{"key":"11639_CR8","doi-asserted-by":"crossref","unstructured":"Soto, E. et al. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. The Journal of Maternal-Fetal & Neonatal Medicine, 25(5), 498\u2013507 (2011).\u00a0","DOI":"10.3109\/14767058.2011.591461"},{"issue":"Suppl","key":"11639_CR9","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.placenta.2010.04.014","volume":"32","author":"T V\u00e1rkonyi","year":"2011","unstructured":"V\u00e1rkonyi, T. et al. Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta \n                           32(Suppl), S21\u20139 (2011).","journal-title":"Placenta"},{"key":"11639_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/molehr\/gar067","volume":"18","author":"K Junus","year":"2012","unstructured":"Junus, K. et al. Gene expression profiling of placentae from women with early- and late-onset pre-eclampsia: down-regulation of the angiogenesis-related genes ACVRL1 and EGFL7 in early-onset disease. Molecular Human Reproduction \n                           18, 146\u2013155 (2012).","journal-title":"Molecular Human Reproduction"},{"key":"11639_CR11","doi-asserted-by":"crossref","unstructured":"Rana, S., Powe, C. E., Salahuddin, S. & Verlohren, S. Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected PreeclampsiaClinical Perspective. Circulation (2012).","DOI":"10.1161\/CIRCULATIONAHA.111.054361"},{"key":"11639_CR12","doi-asserted-by":"publisher","first-page":"H560","DOI":"10.1152\/ajpheart.00133.2005","volume":"290","author":"T Kamba","year":"2006","unstructured":"Kamba, T. et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am. J. Physiol. Heart Circ. Physiol. \n                           290, H560\u201376 (2006).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"11639_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1172\/JCI17423","volume":"111","author":"V Eremina","year":"2003","unstructured":"Eremina, V. et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. \n                           111, 707\u2013716 (2003).","journal-title":"J. Clin. Invest."},{"key":"11639_CR14","doi-asserted-by":"crossref","unstructured":"Eremina, V. et al. VEGF inhibition and renal thrombotic microangiopathy. The New England Journal of Medicine, 358(11), 1129\u20131136 (2008).\u00a0","DOI":"10.1056\/NEJMoa0707330"},{"key":"11639_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-pathol-121808-102149","volume":"5","author":"BC Young","year":"2010","unstructured":"Young, B. C., Levine, R. J. & Karumanchi, S. A. Pathogenesis of preeclampsia. Annual Review of Pathology: Mechanisms of Disease \n                           5, 173\u2013192 (2010).","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"key":"11639_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1161\/HYPERTENSIONAHA.110.164079","volume":"58","author":"J Jebbink","year":"2011","unstructured":"Jebbink, J. et al. Expression of placental FLT1 transcript variants relates to both gestational hypertensive disease and fetal growth. Hypertension \n                           58, 70\u201376 (2011).","journal-title":"Hypertension"},{"key":"11639_CR17","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1096\/fj.07-8809com","volume":"21","author":"CP Thomas","year":"2007","unstructured":"Thomas, C. P., Andrews, J. I. & Liu, K. Z. Intronic polyadenylation signal sequences and alternate splicing generate human soluble Flt1 variants and regulate the abundance of soluble Flt1 in the placenta. FASEB \n                           21, 3885\u20133895 (2007).","journal-title":"FASEB"},{"key":"11639_CR18","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1093\/nar\/gkq198","volume":"38","author":"CPC Thomas","year":"2010","unstructured":"Thomas, C. P. C., Raikwar, N. S. N., Kelley, E. A. E. & Liu, K. Z. K. Alternate processing of Flt1 transcripts is directed by conserved cis-elements within an intronic region of FLT1 that reciprocally regulates splicing and polyadenylation. Nucleic Acids Research \n                           38, 5130\u20135140 (2010).","journal-title":"Nucleic Acids Research"},{"key":"11639_CR19","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.molcel.2011.08.009","volume":"43","author":"S Vorlov\u00e1","year":"2011","unstructured":"Vorlov\u00e1, S. et al. Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation. Molecular Cell \n                           43, 927\u2013939 (2011).","journal-title":"Molecular Cell"},{"key":"11639_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.placenta.2008.12.010","volume":"30","author":"M Heydarian","year":"2009","unstructured":"Heydarian, M. et al. Novel splice variants of sFlt1 are upregulated in preeclampsia. Placenta \n                           30, 250\u2013255 (2009).","journal-title":"Placenta"},{"key":"11639_CR21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard, S. E. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. \n                           111, 649\u2013658 (2003).","journal-title":"J. Clin. Invest."},{"key":"11639_CR22","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.115.05883","volume":"66","author":"KR Palmer","year":"2015","unstructured":"Palmer, K. R. et al. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity. Hypertension \n                           66, 1251\u20131259 (2015).","journal-title":"Hypertension"},{"key":"11639_CR23","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1161\/CIRCULATIONAHA.109.895458","volume":"122","author":"M Noori","year":"2010","unstructured":"Noori, M., Donald, A. E., Angelakopoulou, A., Hingorani, A. D. & Williams, D. J. Prospective Study of Placental Angiogenic Factors and Maternal Vascular Function Before and After Preeclampsia and Gestational Hypertension. Circulation \n                           122, 478\u2013487 (2010).","journal-title":"Circulation"},{"key":"11639_CR24","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1101\/gr.132563.111","volume":"22","author":"A Derti","year":"2012","unstructured":"Derti, A. et al. A quantitative atlas of polyadenylation in five mammals. Genome Research \n                           22, 1173\u20131183 (2012).","journal-title":"Genome Research"},{"key":"11639_CR25","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1261\/rna.2581711","volume":"17","author":"PJ Shepard","year":"2011","unstructured":"Shepard, P. J. et al. Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq. RNA \n                           17, 761\u2013772 (2011).","journal-title":"RNA"},{"key":"11639_CR26","doi-asserted-by":"crossref","unstructured":"Wilkening, S. et al. An efficient method for genome-wide polyadenylation site mapping and RNA quantification. Nucleic Acids Research (2013).","DOI":"10.1093\/nar\/gkt364"},{"key":"11639_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-290","volume":"12","author":"W Zheng","year":"2011","unstructured":"Zheng, W., Chung, L. M. & Zhao, H. Bias detection and correction in RNA-Sequencing data. BMC Bioinformatics \n                           12, 290 (2011).","journal-title":"BMC Bioinformatics"},{"key":"11639_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmeth.1226","volume":"5","author":"A Mortazavi","year":"2008","unstructured":"Mortazavi, A., Williams, B. A., Mccue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature Methods \n                           5, 1\u20138 (2008).","journal-title":"Nature Methods"},{"key":"11639_CR29","first-page":"642","volume":"172","author":"BM Sibai","year":"1995","unstructured":"Sibai, B. M. et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. YMOB \n                           172, 642\u2013648 (1995).","journal-title":"YMOB"},{"key":"11639_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","volume":"330","author":"K Duckitt","year":"2005","unstructured":"Duckitt, K. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ \n                           330, 565\u20130 (2005).","journal-title":"BMJ"},{"key":"11639_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2147\/IBPC.S50641","volume":"ume 8","author":"L Kenny","year":"2015","unstructured":"Kenny, L., English, F. & McCarthy, F. Risk factors and effective management of preeclampsia. IBPC \n                           8, 7\u20136 (2015).","journal-title":"IBPC"},{"key":"11639_CR32","doi-asserted-by":"crossref","unstructured":"Verlohren, S. et al. The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. American Journal of Obstetrics and Gynecology, 206(1) 58.e1\u20138 (2012).","DOI":"10.1016\/j.ajog.2011.07.037"},{"key":"11639_CR33","doi-asserted-by":"crossref","unstructured":"Verlohren, S. et al. An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia. American Journal of Obstetrics and Gynecology, 202(2), 161.e1\u2013161.e11 (2010).","DOI":"10.1016\/j.ajog.2009.09.016"},{"key":"11639_CR34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/HYPERTENSIONAHA.111.182170","volume":"59","author":"A Rajakumar","year":"2012","unstructured":"Rajakumar, A. et al. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension \n                           59, 256\u2013264 (2012).","journal-title":"Hypertension"},{"key":"11639_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1235","volume":"43","author":"EE Heyer","year":"2015","unstructured":"Heyer, E. E., Ozadam, H., Ricci, E. P., Cenik, C. & Moore, M. J. An optimized kit-free method for making strand-specific deep sequencing libraries from RNA fragments. Nucleic Acids Research \n                           43, e2 (2015).","journal-title":"Nucleic Acids Research"},{"key":"11639_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/nar\/gki158","volume":"33","author":"B Tian","year":"2005","unstructured":"Tian, B., Hu, J., Zhang, H. & Lutz, C. S. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Research \n                           33, 201\u2013212 (2005).","journal-title":"Nucleic Acids Research"},{"key":"11639_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/srep13336","volume":"5","author":"S S\u00f5ber","year":"2015","unstructured":"S\u00f5ber, S. et al. Extensive shift in placental transcriptome profile in preeclampsia and placental origin of adverse pregnancy outcomes. Sci Rep \n                           5, 13336 (2015).","journal-title":"Sci Rep"},{"key":"11639_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq. 2. Genome Biology \n                           15, 31 (2014).","journal-title":"Genome Biology"},{"key":"11639_CR39","doi-asserted-by":"publisher","first-page":"W317","DOI":"10.1093\/nar\/gkp416","volume":"37","author":"R Nogales-Cadenas","year":"2009","unstructured":"Nogales-Cadenas, R. et al. GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Research \n                           37, W317\u2013W322 (2009).","journal-title":"Nucleic Acids Research"},{"key":"11639_CR40","doi-asserted-by":"publisher","first-page":"W478","DOI":"10.1093\/nar\/gks402","volume":"40","author":"D Tabas-Madrid","year":"2012","unstructured":"Tabas-Madrid, D., Nogales-Cadenas, R. & Pascual-Montano, A. GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Research \n                           40, W478\u2013W483 (2012).","journal-title":"Nucleic Acids Research"},{"key":"11639_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-1-r3","volume":"8","author":"P Carmona-Saez","year":"2007","unstructured":"Carmona-Saez, P., Chagoyen, M., Tirado, F., Carazo, J. M. & Pascual-Montano, A. GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biology \n                           8, R3 (2007).","journal-title":"Genome Biology"},{"key":"11639_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00190","volume":"4","author":"M Kn\u00f6fler","year":"2013","unstructured":"Kn\u00f6fler, M. & Pollheimer, J. Human placental trophoblast invasion and differentiation: a particular focus on Wnt signaling. Front Genet \n                           4, 190 (2013).","journal-title":"Front Genet"},{"key":"11639_CR43","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.placenta.2009.01.012","volume":"30","author":"V Sitras","year":"2009","unstructured":"Sitras, V. et al. Differential placental gene expression in severe preeclampsia. Placenta \n                           30, 424\u2013433 (2009).","journal-title":"Placenta"},{"key":"11639_CR44","first-page":"33","volume":"31","author":"SE Maynard","year":"2011","unstructured":"Maynard, S. E. & Karumanchi, S. A. Angiogenic factors and preeclampsia. YSNEP \n                           31, 33\u201346 (2011).","journal-title":"YSNEP"},{"key":"11639_CR45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1515\/jpm-2013-0082","volume":"41","author":"T Chaiworapongsa","year":"2013","unstructured":"Chaiworapongsa, T. et al. Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa. J Perinat Med \n                           41, 485\u2013504 (2013).","journal-title":"J Perinat Med"},{"key":"11639_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/srep14107","volume":"5","author":"T Kaartokallio","year":"2015","unstructured":"Kaartokallio, T., Cervera, A., Kyll\u00f6nen, A., Laivuori, K. & FINNPEC Core Investigator Group. Gene expression profiling of pre-eclamptic placentae by RNA sequencing. Sci Rep \n                           5, 14107 (2015).","journal-title":"Sci Rep"},{"key":"11639_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116508","volume":"10","author":"K Leavey","year":"2015","unstructured":"Leavey, K., Bainbridge, S. A. & Cox, B. J. Large scale aggregate microarray analysis reveals three distinct molecular subclasses of human preeclampsia. PLoS ONE \n                           10, e0116508 (2015).","journal-title":"PLoS ONE"},{"key":"11639_CR48","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.tem.2013.05.001","volume":"24","author":"J Nautiyal","year":"2013","unstructured":"Nautiyal, J., Christian, M. & Parker, M. G. Distinct functions for RIP140 in development, inflammation, and metabolism. Trends Endocrinol. Metab. \n                           24, 451\u2013459 (2013).","journal-title":"Trends Endocrinol. Metab."},{"key":"11639_CR49","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","volume":"23","author":"Y Lee","year":"2004","unstructured":"Lee, Y. et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J \n                           23, 4051\u20134060 (2004).","journal-title":"EMBO J"},{"key":"11639_CR50","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1016\/j.ajog.2015.05.057","volume":"213","author":"J-F Mouillet","year":"2015","unstructured":"Mouillet, J.-F., Ouyang, Y., Coyne, C. B. & Sadovsky, Y. MicroRNAs in placental health and disease. Amer J Obst and Gyn\u00a0\n                           213, S163\u201372 (2015).","journal-title":"J Obst and Gyn"},{"key":"11639_CR51","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ajpath.2011.04.035","volume":"179","author":"DC Lee","year":"2011","unstructured":"Lee, D. C. et al. miR-210 Targets Iron-Sulfur Cluster Scaffold Homologue in Human Trophoblast Cell Lines. Am. J. Pathol. \n                           179, 590\u2013602 (2011).","journal-title":"Am. J. Pathol."},{"key":"11639_CR52","doi-asserted-by":"publisher","first-page":"261.e1","DOI":"10.1016\/j.ajog.2007.01.008","volume":"196","author":"BL Pineles","year":"2007","unstructured":"Pineles, B. L. et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Amer J Obst and Gyn \n                           196, 261.e1\u2013261.e6 (2007).","journal-title":"Amer J Obst and Gyn"},{"key":"11639_CR53","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nsmb1167","volume":"13","author":"GM Borchert","year":"2006","unstructured":"Borchert, G. M., Lanier, W. & Davidson, B. L. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol \n                           13, 1097\u20131101 (2006).","journal-title":"Nat Struct Mol Biol"},{"key":"11639_CR54","doi-asserted-by":"publisher","first-page":"566.e1","DOI":"10.1016\/j.ajog.2008.04.020","volume":"199","author":"DA Enquobahrie","year":"2008","unstructured":"Enquobahrie, D. A. et al. Differential placental gene expression in preeclampsia. Amer J Obst and Gyn\u00a0199, 566.e1\u2013566.e11 (2008).","journal-title":"Amer J Obst and Gyn"},{"key":"11639_CR55","doi-asserted-by":"crossref","unstructured":"Luo, R. et al. Hypoxia-inducible miR-210 contributes to preeclampsia via targeting thrombospondin type I domain containing 7A. Sci Rep 1\u201311 (2016).","DOI":"10.1038\/srep19588"},{"key":"11639_CR56","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1161\/HYPERTENSIONAHA.113.02647","volume":"63","author":"P Xu","year":"2014","unstructured":"Xu, P. et al. Variations of microRNAs in human placentas and plasma from preeclamptic pregnancy. Hypertension \n                           63, 1276\u20131284 (2014).","journal-title":"Hypertension"},{"key":"11639_CR57","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/BJ20141138","volume":"468","author":"CS Gonsalves","year":"2015","unstructured":"Gonsalves, C. S. et al. Erythropoietin-mediated expression of placenta growth factor is regulated via activation of hypoxia-inducible factor-1\u03b1 and post-transcriptionally by miR-214 in sickle cell disease. Biochem. J. \n                           468, 409\u2013423 (2015).","journal-title":"Biochem. J."},{"key":"11639_CR58","doi-asserted-by":"publisher","first-page":"e44206","DOI":"10.1371\/journal.pone.0044206","volume":"7","author":"H Xia","year":"2012","unstructured":"Xia, H., Ooi, L. L. P. J. & Hui, K. M. MiR-214 Targets \u03b2-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma. PLoS ONE \n                           7, e44206\u201313 (2012).","journal-title":"PLoS ONE"},{"key":"11639_CR59","doi-asserted-by":"publisher","first-page":"19960","DOI":"10.18632\/oncotarget.6963","volume":"7","author":"W Zang","year":"2016","unstructured":"Zang, W. et al. Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma. Oncotarget \n                           7, 19960\u201319974 (2016).","journal-title":"Oncotarget"},{"key":"11639_CR60","unstructured":"Turanov, A. A. et al. Development of Therapeutic anti-sFLT1 siRNA for the Treatment of Preeclampsia. \u00a0Manuscript in preparation."},{"key":"11639_CR61","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.113.115279","volume":"90","author":"K Biadasiewicz","year":"2014","unstructured":"Biadasiewicz, K. et al. Extravillous trophoblast-associated ADAM12 exerts pro-invasive properties, including induction of integrin beta 1-mediated cellular spreading. Biology of Reproduction \n                           90, 101 (2014).","journal-title":"Biology of Reproduction"},{"key":"11639_CR62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/19336918.2015.1083668","volume":"10","author":"JK Christians","year":"2016","unstructured":"Christians, J. K. & Beristain, A. G. ADAM12 and PAPP-A: Candidate regulators of trophoblast invasion and first trimester markers of healthy trophoblasts. Cell Adh Migr \n                           10, 147\u2013153 (2016).","journal-title":"Cell Adh Migr"},{"key":"11639_CR63","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1210\/jc.2009-0017","volume":"94","author":"CP Thomas","year":"2009","unstructured":"Thomas, C. P. et al. A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia. J. Clin. Endocrinol. Metab. \n                           94, 2524\u20132530 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"11639_CR64","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1161\/CIRCRESAHA.108.171504","volume":"102","author":"S Sela","year":"2008","unstructured":"Sela, S. et al. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Circulation Research \n                           102, 1566\u20131574 (2008).","journal-title":"Circulation Research"},{"key":"11639_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119547","volume":"10","author":"G Szalai","year":"2015","unstructured":"Szalai, G. et al. Full-Length Human Placental sFlt-1-e15a Isoform Induces Distinct Maternal Phenotypes of Preeclampsia in Mice. PLoS ONE \n                           10, e0119547 (2015).","journal-title":"PLoS ONE"},{"key":"11639_CR66","doi-asserted-by":"publisher","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","volume":"90","author":"RL Kendall","year":"1993","unstructured":"Kendall, R. L. & Thomas, K. A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. PNAS USA \n                           90, 10705\u201310709 (1993).","journal-title":"PNAS USA"},{"key":"11639_CR67","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1530\/JME-16-0156","volume":"58","author":"J Nautiyal","year":"2017","unstructured":"Nautiyal, J. Transcriptional coregulator RIP140: an essential regulator of physiology. J. Mol. Endocrinol. \n                           58, R147\u2013R158 (2017).","journal-title":"J. Mol. Endocrinol."},{"key":"11639_CR68","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nature05249","volume":"443","author":"BK Ambati","year":"2006","unstructured":"Ambati, B. K. et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature \n                           443, 993\u2013997 (2006).","journal-title":"Nature"},{"key":"11639_CR69","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2183\/pjab.87.167","volume":"87","author":"M Shibuya","year":"2011","unstructured":"Shibuya, M. Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia. Proc. Jpn. Acad, Ser. B \n                           87, 167\u2013178 (2011).","journal-title":"Proc. Jpn. Acad, Ser. B"},{"key":"11639_CR70","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1210\/en.2004-0533","volume":"145","author":"T Nagamatsu","year":"2004","unstructured":"Nagamatsu, T. et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology \n                           145, 4838\u20134845 (2004).","journal-title":"Endocrinology"},{"key":"11639_CR71","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/humrep\/den114","volume":"23","author":"C Munaut","year":"2008","unstructured":"Munaut, C. et al. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Human Reproduction \n                           23, 1407\u20131415 (2008).","journal-title":"Human Reproduction"},{"key":"11639_CR72","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1042\/BJ20101490","volume":"436","author":"T Ikeda","year":"2011","unstructured":"Ikeda, T. et al. Hypoxia down-regulates sFlt-1 (sVEGFR-1) expression in human microvascular endothelial cells by a mechanism involving mRNA alternative processing. Biochem. J. \n                           436, 399\u2013407 (2011).","journal-title":"Biochem. J."},{"key":"11639_CR73","doi-asserted-by":"crossref","unstructured":"Ikeda, T. et al. Regulation of soluble Flt-1 (VEGFR-1) production by hnRNP D and protein arginine methylation. Molecular and Cellular Biochemistry 1\u201310 (2016).","DOI":"10.1007\/s11010-015-2649-y"},{"key":"11639_CR74","doi-asserted-by":"publisher","first-page":"e10236","DOI":"10.1371\/journal.pone.0010236","volume":"5","author":"Y Ciribilli","year":"2010","unstructured":"Ciribilli, Y. et al. The Coordinated P53 and Estrogen Receptor Cis-Regulation at an FLT1 Promoter SNP Is Specific to Genotoxic Stress and Estrogenic Compound. PLoS ONE \n                           5, e10236\u201315 (2010).","journal-title":"PLoS ONE"},{"key":"11639_CR75","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nm.1877","volume":"14","author":"M Jinnin","year":"2008","unstructured":"Jinnin, M. et al. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat. Med. \n                           14, 1236\u20131246 (2008).","journal-title":"Nat. Med."},{"key":"11639_CR76","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1006\/geno.2002.6703","volume":"79","author":"TD Barber","year":"2002","unstructured":"Barber, T. D. et al. Identification of Target Genes Regulated by PAX3 and PAX3\u2013FKHR in Embryogenesis and Alveolar Rhabdomyosarcoma. Genomics \n                           79, 278\u2013284 (2002).","journal-title":"Genomics"},{"key":"11639_CR77","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1128\/MCB.01742-06","volume":"27","author":"D Menendez","year":"2007","unstructured":"Menendez, D. et al. A Single-Nucleotide Polymorphism in a Half-Binding Site Creates p53 and Estrogen Receptor Control of Vascular Endothelial Growth Factor Receptor 1. Molecular and Cellular Biology \n                           27, 2590\u20132600 (2007).","journal-title":"Molecular and Cellular Biology"},{"key":"11639_CR78","doi-asserted-by":"crossref","unstructured":"Das, B. et al. A Hypoxia-Driven Vascular Endothelial Growth Factor\/Flt1 Autocrine Loop Interacts with Hypoxia-Inducible Factor-1 through Mitogen-Activated Protein Kinase\/Extracellular Signal-Regulated Kinase 1\/2 Pathway in Neuroblastoma. Cancer Research \n                           65, 7267\u20137275 (2005).","DOI":"10.1158\/0008-5472.CAN-04-4575"},{"key":"11639_CR79","doi-asserted-by":"publisher","first-page":"28107","DOI":"10.1074\/jbc.M115.662197","volume":"290","author":"N Koyano-Nakagawa","year":"2015","unstructured":"Koyano-Nakagawa, N. et al. Feedback Mechanisms Regulate Ets Variant 2(Etv2) Gene Expression and Hematoendothelial Lineages. J. Biol. Chem. \n                           290, 28107\u201328119 (2015).","journal-title":"J. Biol. Chem."},{"key":"11639_CR80","doi-asserted-by":"publisher","first-page":"9744","DOI":"10.1128\/MCB.24.22.9744-9751.2004","volume":"24","author":"V Begay","year":"2004","unstructured":"Begay, V., Smink, J. & Leutz, A. Essential Requirement of CCAAT\/Enhancer Binding Proteins in Embryogenesis. Molecular and Cellular Biology \n                           24, 9744\u20139751 (2004).","journal-title":"Molecular and Cellular Biology"},{"key":"11639_CR81","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.febslet.2007.11.017","volume":"582","author":"R White","year":"2007","unstructured":"White, R. et al. Role of RIP140 in metabolic tissues: Connections to disease. FEBS Letters \n                           582, 39\u201345 (2007).","journal-title":"FEBS Letters"},{"key":"11639_CR82","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10456-014-9452-3","volume":"18","author":"A Pratt","year":"2014","unstructured":"Pratt, A. et al. Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia. Angiogenesis \n                           18, 115\u2013123 (2014).","journal-title":"Angiogenesis"},{"key":"11639_CR83","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1210\/jc.2005-0078","volume":"90","author":"N Soleymanlou","year":"2005","unstructured":"Soleymanlou, N. et al. Molecular Evidence of Placental Hypoxia in Preeclampsia. J. Clin. Endocrinol. Metab. \n                           90, 4299\u20134308 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"11639_CR84","first-page":"R1085","volume":"291","author":"O Nevo","year":"2006","unstructured":"Nevo, O. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. AJP: Regulatory, Integrative and Comparative Physiology \n                           291, R1085\u2013R1093 (2006).","journal-title":"AJP: Regulatory, Integrative and Comparative Physiology"},{"key":"11639_CR85","doi-asserted-by":"crossref","unstructured":"Rajakumar, A., Whitelock, K. A. & Weissfeld, L. A. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2\u03b1,in placentas from women with preeclampsia. Biology of Reproduction \n                           64, 499\u2013506 (2001).","DOI":"10.1093\/biolreprod\/64.2.499"},{"key":"11639_CR86","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/19336918.2016.1170258","volume":"10","author":"EJ Davies","year":"2016","unstructured":"Davies, E. J. et al. Epithelial-mesenchymal transition during extravillous trophoblast differentiation. Cell Adh Migr \n                           10, 310\u2013321 (2016).","journal-title":"Cell Adh Migr"},{"key":"11639_CR87","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/aogs.13006","volume":"95","author":"BM Luef","year":"2016","unstructured":"Luef, B. M. et al. Validation of hospital discharge diagnoses for hypertensive disorders of pregnancy. Acta Obstet Gynecol Scand \n                           95, 1288\u20131294 (2016).","journal-title":"Acta Obstet Gynecol Scand"},{"key":"11639_CR88","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/GRF.0000000000000267","volume":"60","author":"AK Malshe","year":"2017","unstructured":"Malshe, A. K. & Sibai, B. M. Angiogenic and Antiangiogenic Markers for Prediction and Risk Classification of Preeclampsia. Clin Obstet Gynecol \n                           60, 134\u2013140 (2017).","journal-title":"Clin Obstet Gynecol"},{"key":"11639_CR89","unstructured":"American College of Obstetricians and GynecologistsTask Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. in 122, 1122\u20131131 (2013)."},{"key":"11639_CR90","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1161\/CIRCULATIONAHA.115.015721","volume":"132","author":"A Goel","year":"2015","unstructured":"Goel, A. et al. Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period. Circulation \n                           132, 1726\u20131733 (2015).","journal-title":"Circulation"},{"key":"11639_CR91","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1093\/nar\/gku1235","volume":"43","author":"EE Heyer","year":"2015","unstructured":"Heyer, E. E., Ozadam, H., Ricci, E. P., Cenik, C. & Moore, M. J. An optimized kit-free method for making strand-specific deep sequencing libraries from RNA fragments. Nucleic Acids Research \n                           43, e2\u2013e2 (2015).","journal-title":"Nucleic Acids Research"},{"key":"11639_CR92","doi-asserted-by":"publisher","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. Journal \n                           17, 10 (2011).","journal-title":"EMBnet. Journal"},{"key":"11639_CR93","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1093\/bioinformatics\/btt446","volume":"29","author":"S Sheppard","year":"2013","unstructured":"Sheppard, S., Lawson, N. D. & Zhu, L. J. Accurate identification of polyadenylation sites from 3\u2032 end deep sequencing using a naive Bayes classifier. Bioinformatics \n                           29, 2564\u20132571 (2013).","journal-title":"Bioinformatics"},{"key":"11639_CR94","doi-asserted-by":"crossref","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B \u2026 (1995).","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11639-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11639-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11639-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:19:38Z","timestamp":1671794378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11639-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,22]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["11639"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-11639-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,22]]},"assertion":[{"value":"11 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.A.K. is a co-inventor on multiple patents for preeclampsia diagnostics and therapies that are held by Beth Israel Deaconess Medical Center and reports serving as a consultant to Thermofisher Scientific and has financial interest in Aggamin LLC. The remaining authors report no conflicts.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12139"}}